HOME >> BIOLOGY >> NEWS
Echinacea Symposium Presents New Research On Chernobyl Victims

The results from a long-term clinical study in the Ukraine on the use of Echinacea to treat victims of the Chernobyl disaster is among the new studies to be presented at the 1999 International Echinacea Symposium June 3-5 in Kansas City, MO.

Dr. Victoriya F. Pochernyayeva, a leading researcher from Ukraine and the former Soviet Union, will review the results of her long-term studies including:

  • An analysis of how effectively Echinacea purpurea, consumed as a food additive in fruit juices and other non-alcoholic and alcoholic drinks, protects people who are exposed to radiation. Based on her findings, Dr. Pochernyayeva recommends ways Echinacea purpurea food additives can be used most effectively to safeguard a population that is facing high levels of radiation exposure;
  • A study of how Echinacea purpurea can protect the male reproductive system from the effects of radiation;
  • A study of how effectively Echinacea purpurea can protect organs and tissues from radiation damage.

The world's leading Echinacea researcher, Dr. Rudolf Bauer, is the keynote speaker. Dr. Bauer, professor at the Institute of Pharmaceutical Biology, University of Dusseldorf, has published more than 100 research papers and has edited a book on Echinacea. He's currently researching the quality aspects of Echinacea preparations, constituents and pharmacological activity of Echinacea species.

The event is hosted by the American Herbal Products Association. Sponsors include Nature's Way, Botanicals International, Bioforce USA, Finzelberg North America, Rexall Sundown, Indena USA, and Plantation Medicinals.

Who: Some 150 researchers, scientists and other professionals from the herbal industry.

What: 1999 International Echinacea Symposium

Where: Ritz-Carlton, Kansas City, MO.

When: June 3-5, 1999

Why: To present the latest clinical research, and learn about the
'"/>

Contact: Brian Ruberry
br@rubcomm.com
301-947-1662
American Herbal Products Association
11-May-1999


Page: 1 2 3

Related biology news :

1. NIH funds botanical center in Iowa to study health effects of Echinacea and St. Johns wort
2. Worlds Leading Echinacea Researchers To Examine Latest Scientific Findings On "Natures Gentle Antibiotic"
3. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
4. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
5. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
6. Health of worlds sea lions the focus of Wakefield Symposium
7. Chemical signals health of brain cells Symposium
8. Final Alert: 16th EORTC NCI AACR Symposium
9. 16th EORTC NCI AACR Symposium
10. Symposium to tackle questions of genetic engineering and biodiversity
11. Fostering Diversity in the Sciences Symposium

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Echinacea Symposium Presents New Research Chernobyl Victims

(Date:7/25/2014)... a molecular testing panel developed at UPMC greatly ... surgery for patients with thyroid nodules and cancer, ... Institute (UPCI), partner with UPMC CancerCenter., The test, ... other diagnostic testing agencies, improved the chances of ... percent, according to the study published this month ...
(Date:7/24/2014)... July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the ... randomized, active control Phase 3 study of Zerenex (ferric ... for the treatment of hyperphosphatemia in patients with end-stage ... binding and iRon delivery with FErric CiTrate in EsrD) ... the American Society of Nephrology ( JASN ). ...
(Date:7/24/2014)... on different species of fish, according to a ... Exeter which tested fish anti-predator behaviour. , ... predator model when exposed to additional noise, whereas ... , Lead author Dr Irene Voellmy of Bristol,s ... many aquatic environments have increased substantially during the ...
Breaking Biology News(10 mins):Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4
(Date:7/24/2014)... most natural and synthetic processes prefer to settle ... or energyit is within the realm of non-equilibrium ... constant changes in energy and phases, such as ... conditions allow humans to regulate their body temperature, ... with seismic activity. , But even though ...
(Date:7/24/2014)... July 24, 2014 Your cell ... in modeling lithium-ion battery storage capacity. , New ... a theoretical model created at Lawrence Livermore ... that predicts how carbon components will perform as ... emphasizes the urgent need for higher-performance batteries. Several ...
(Date:7/24/2014)... July 24, 2014 Three companies from ... in Livestrong’s Big C Competition. Out of 700 competition ... headed to the semi-final round. In this round twenty ... accelerator program, complete with mentoring from thought-leaders and medical ... part of the angelMD commitment to the Livestrong vision ...
(Date:7/24/2014)... N.J. , July 24, 2014 ... provider of regulatory and ethical review services for ... Alliance Biosciences. Formerly a division of ... was the leading biosafety and biosecurity consulting firm ... With this addition, WCG,s biosafety division – WCG ...
Breaking Biology Technology:New approach to form non-equilibrium structures 2Getting More Life out of Lithium-ion Batteries 23 angelMD Startups Make Livestrong Big C Semi-finals 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3
Cached News: